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Abstract 
Diagnostic tools for the identification and confirmation of animal diseases have been 
evolving rapidly over the last decade, with diseases of aquatic animals being no exception. 
Hence, case definitions used in surveillance may now include molecular and genomic 
components and ultimately be based on the entire genome of a pathogen.  While the 
opportunities brought on by this change in our ability to define and differentiate organisms 
are manifold, there are also challenges. These include the need to consider typing tool 
characteristics during sampling design, but also the re-thinking of diagnostic protocols and 
standards for the meaningful interpretation of the increasingly complex data presented to 
surveillance managers. These issues are illustrated for aquaculture using the example of 
multi-country surveillance of antimicrobial resistance of Aeromonas spp. strains isolated 
from rainbow trouts (Oncorhynchus mykiss) in Europe. In order to fully exploit the 
opportunities of molecular and genomic information, a multi-disciplinary approach is needed 
to develop harmonised diagnostic procedures and modified surveillance designs for 
aquaculture as well as for terrestrial animal production. This will require adjustments in the 
relevant standards applicable to assess food safety and trade risks. 
 
Introduction 
Diagnostic tools for the identification and confirmation of animal diseases have been 
evolving rapidly over the last decade, with diseases of aquatic animals being no exception. 
While polymerase chain reaction (PCR) has been implemented for the detection of antigens 
since the last millennium (Cunningham, 2002), new tools have been emerging more recently 
and are soon likely to be part of our standard diagnostic repertoire. These include kits based 
on sequencing certain parts of the genome of micro-organisms and – ultimately – diagnostics 
considering the information available on the entire genome of a bacterium, virus or parasite 
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(van Borm et al., 2015; Bayliss et al., 2017). DNA sequencing platforms can already offer 
accurate whole genome sequences (WGS) for bacteria in less than a day (Reuter et al., 2013). 
Generally, molecular surveillance – and genomic surveillance in analogue – can be defined as 
“the systematic, continuous or repeated measurement, collection, collation, analysis, 
interpretation and timely dissemination of molecular-level information about micro-
organisms. These data are then used to describe health hazard occurrence and to contribute to 
the planning, implementation and evaluation of risk mitigation actions” (Muellner et al., 
2016). While molecular and genomic surveillance is relevant for all livestock and animal-
derived foods, this article focuses on aquaculture specifically. 
 
Surveillance is used for a range of objectives in aquaculture. These objectives include the 
confirmation of suspected disease cases in an aquaculture facility, pond, waterway or 
catchment area, i.e. surveillance with a focus on control (Muellner et al., 2016). This is 
particularly relevant after an outbreak has occurred. An alternative objective with a more 
strategic focus is to provide feedback on ongoing disease control efforts (e.g. an eradication 
programme) or the demonstration of absence of disease or infection, again for a defined 
population (Peeler & Otte, 2014). The latter is particularly relevant in the context of trade. 
Fish and shellfish are the world’s most-traded agricultural goods (Bellmann et al., 2016). 
Most fish and shellfish are traded internationally leading to complex global food systems 
within which the quality and safety, but most importantly the biosecurity of products strongly 
depends on rigorous documentation of the disease-free status. For example, import bans have 
been called for to prevent the introduction of Tilapia Lake Virus from Asia to Zambia 
following an international alert (FAO, 2017). Another example is the risk of introduction of 
White Spot disease through shrimp import, which recently led to trade disruption and 
outbreaks of the disease in Australia (Anonymous, 2017). The trade of ornamental fish is also 
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affected by health status of the country of origin. Surveillance systems are therefore a critical 
prerequisite for the sustainable growth of the aquaculture sector. 
 
Outbreaks of infectious diseases of economic  relevance are being reported in all intensive 
aquaculture production regions (Rodger, 2016). Surveillance can help detect outbreaks early 
and is essential for documenting the progress of disease control, but surveillance also incurs 
costs which need to be balanced against the potential benefits (Stärk & Oidtmann, 2015). The 
minimum requirements for animal health surveillance are set out in the Aquatic Animal 
Health Code by the World Organisation of Animal Health (OIE, 2017). This reference 
document sets out the standards for trade as agreed by participating countries and details 
procedures for risk assessment and surveillance.  
  
Within a surveillance programme, diagnostic tests are a major cost item. More efficient 
diagnostic methods are therefore attractive and should be considered when evaluating 
surveillance, provided that the quality of test result is equivalent to alternative tests.  Higher 
costs could also be justified if outweighed by other advantages such as improved pathogen 
characterization, more rapid availability of results or practical advantages of sampling and 
transport. Surveillance evaluation - based on the experience from the human and terrestrial 
animal health field - is now starting to be applied to the aquaculture and marine environment 
in recognition of the need to create programmes that are as fit-for purpose and as cost-
efficient as possible (Muellner et al., 2017). Increased precision of surveillance can be 
reached e.g. by including elements of risk assessment to develop risk-based surveillance 
designs. Likewise molecular and genomic tools can improve surveillance programs and bring 
many new opportunities, e.g. improved resolution of surveillance through improved case 
definitions. Case definitions are typically based on either clinical features of a disease 
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(syndromic surveillance) or – preferably – on the outcomes of diagnostic tests. The latter can 
be based on antibody or antigen detection. Furthermore, the use of genomic and molecular 
tools allows for improved precision of case definitions for exampling by being able to define 
specific genetic variants.  
 
Surveillance based on molecular and genomic tools has a range of strength and weaknesses, 
and offers opportunities as well as threats as shown in Figure 1. These are applicable to 
surveillance for terrestrial animal diseases as well as for those conditions affecting aquatic 
animals. Their strengths are mostly related to increased resolution and precision as well as to 
the rapid availability of test results. However, weaknesses such as initial investment costs, 
complexity of the bioinformatics processing and – perhaps most importantly – the current 
lack of standardization and quality assurance severely hinder the general recognition and 
adoption of these methods as a basis for policy and trade decision making. At the same time, 
opportunities for outbreak detection, increased efficiency in the use of laboratory capacity 
and additional information gained from whole genome sequencing provide considerable 
value to disease detection and control. However the threats can be overcome provided that 
trans-disciplinary teams design and operate such surveillance programmes, and that relevant 
standards keep pace with the evolution of diagnostic tools.   
 
While the opportunities provided by molecular and genomic tools are transforming 
epidemiology (Kao, 2014), and in consequence disease surveillance, interpretation of results 
remains a challenge (Muellner 2016; Kao, 2014). It has previously been noted that advances 
in typing methods are no substitute for adequate surveillance or study design, and best 
practices for molecular surveillance are much needed to successfully implement the vision 
(Muellner 2016). 
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In molecular surveillance, conventional surveillance approaches are utilized, with molecular 
typing added where considered necessary to improve the resolution of the data. This also 
means that we are moving from an environment of binary testing outcomes (positive vs. 
negative result) to increasingly complex results that require re-thinking of epidemiological 
response and explanatory variables (Muellner 2013). It is the objective of this article to 
systematically discuss the advantages and disadvantages of this “next generation” 
surveillance with specific emphasis on aquatic animals farmed or harvested for food.  
 
Surveillance design: Where does typing data make a difference?  
Similar to surveillance conducted in other sectors, surveillance of aquatic populations can be 
described by a series of elements including the surveillance objective, the case definition, the 
sampling strategy and intensity, the diagnostic tools used, the results and their 
communication to inform decision making. Among these elements of the disease surveillance 
cycle, the change from conventional to molecular diagnostic approaches affects mostly the 
data collection, sampling design, interpretation and communication of laboratory data. A 
broad range of molecular typing methods exits including very well established methods such 
as polymerase chain reaction (PCR). But increasingly, methods are extending to DNA-
sequence based approaches including partial or whole genome sequencing (EFSA, 2013, 
2014). The latter allow the accumulation of vast amounts of information from the genome of 
a single pathogen. Several authors have compiled reviews of available techniques (e.g. Sabat 
2013, EFSA 2013, 2014) relevant to specific objectives or pathogen groups. Importantly, 
once sequence data is available it can be fitted to evolutionary and epidemiological models, 
allowing  new insights into pathogen evolution, the nature of associations between strains of 
pathogens and host species, as well as aspects of between-host transmission (Muellner et al. 
2013).  
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However, the interpretation of typing outcomes has become increasingly challenging in a 
research context alone; but even more so when the information provided needs to be linked to 
surveillance outcomes. Due to the complexity of the data, interpretation is no longer black 
and white but consists of continuous measures of relatedness and similarity which require 
novel analytical methods and new thinking. While the molecular information is highly useful 
in epidemiology, for example when molecular markers are used as risk factors, the analysis is 
not without challenges. For example, the time sequence between temporal occurrence of 
genetic changes and the spatio-temporal scale of a surveillance objective need to be aligned 
to ensure the scales of the investigations match (Muellner 2011). Also, sequence data as 
currently stored in public databases often lack accompanying information regarding the 
sampling location, clinical signs and other relevant characteristics that are essential for 
correct epidemiological interpretation. Therefore, such information should be added, for 
example to existing databases for fish pathogens (Fish Pathogen Database). 
 
The latter might be further complicated by the occurrence of clustering (i.e. several strains 
may have originated from the same sample) which challenges correct epidemiological 
interpretation. Also, when genomic data is obtained subsequent to a culturing step, the 
culture(s) selected for analysis may not fully represent the heterogeneity within the sample. 
Several samples may need to be taken to fully capture within sample heterogeneity (Döpfer et 
al, 2008) and depending on the sampling design, the heterogeneity within the targeted host 
population may also be biased.  
 
Aspects of bias are likely widened when molecular methods are used as the underestimation 
of the presence of rare genes, detection limits of diagnostic approaches, impact of using 
correction factors or the normalisation of metagenomics results are currently not quantified. 
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For example, the emergence of the mcr-1 resistance gene in bacteria initially led to a world-
wide alert only to reveal later that this gene had already been circulating for many years 
(Chen et al., 2017). These issues complicate the interpretation of standard surveillance terms 
such as “sensitivity” and “specificity”, but also “coverage” and “accuracy”. Infectious disease 
epidemiologists – and probably also others – should be aware of this.  
 
An illustrated example: Antimicrobial resistance surveillance in aquaculture in Europe 
While much focus in aquaculture is on economically devastating viruses such as salmon 
infectious anaemia, the occurrence of antimicrobial resistance (AMR) genes in aquatic 
animals is of increasing concern, particularly if considered as part of the human food chain 
(Done et al., 2015). Along with policy interventions aiming to reduce the frequency of 
resistance, the need for accompanying surveillance is highlighted by all relevant 
organisations, including the OIE. However, due to the large number of relevant resistance 
genes and their occurrence across numerous relevant species of micro-organisms, the design 
of effective and efficient surveillance systems is challenging and the subject of ongoing 
research.  
 
The following difficulties in terms of classifying resistant isolates are commonly encountered 
when using conventional microbiological approaches. First, a lack of defined breakpoints to 
classify isolates into susceptible, intermediate and resistant hinders the analysis and 
interpretation of the sampling data. The definition of breakpoints depends on the availability 
of suitable isolates, which are often missing. Additionally, for some species such as 
Aeromonas spp., the classification to the species level is challenging because of their large 
taxonomic diversity (Kozińska, 2007). It is known that Aeromonas species contain 3–5 
hybridization groups, and at least 14 phenotypically described separate Aeromonas species 
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are recognized (Carnahan & Joseph 2005). Therefore, information concerning resistance of 
particular Aeromonas spp. is unprecise. This can be improved by the use of molecular tools. 
For example, additional sequencing of 16S rDNA gene fragment can be used to determine 
particular species, and to link it with MIC values; thus illustrating the value of sequencing to 
refine and improve surveillance case definitions. 
  
A number of challenges related to the use of whole genome sequencing can also be 
encountered in the context of AMR surveillance for aquaculture as well as terrestrial animals. 
Particularly the lack of standardised DNA extraction protocols introduces variability into 
surveillance results. It is known that DNA extraction yield, quality and composition varies 
significantly according to the protocol applied (Knudsen et al., 2016). To address this, a 
proposed standard operating procedure is required that allows for the valid comparison of 
results between laboratories as well as between studies (Munk et al., 2017). Recent 
experience also emphasises the need for benchmarking of methods and analytical approaches 
when using genome-based resistance data (Clausen et al., 2016).  
 
We therefore argue that further work is urgently needed to integrate and compare AMR 
surveillance data originating from culture- vs. genome-based methods within antimicrobial 
resistance surveillance activities (Ellington et al., 2017). Regarding the latter, first progress 
has been made in terms of proposing protocols that integrate both epidemiological and 
microbiological aspects (Munk et al., 2017). However, further improvements including the 
integration of basic concepts of quality assurance are needed to harmonise results. The 
adoption and further development of guidance is important as impaired diagnostic 
interpretation is carried forward into full risk assessments where they can threaten the validity 
of the overall surveillance outcomes and their interpretation. Such methodological 
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harmonisation is an essential requirement before molecular methods can be included in 
international surveillance standards such as the Aquatic Animal Health Code.  
 
From the micro to the macro  
At present, molecular and genomic information are already used in a range of surveillance 
settings (Muellner et al., 2011). The rapid availability of results, the ability to investigate 
outbreaks and to establish links between related isolates as well as the possibility to ship 
extracted DNA without a cool chain are all contributing factors to the attractiveness of 
molecular and genomic typing tools (Figure 1). As with any novel technology, there are 
clearly also challenges to be overcome. In the context of food safety and international trade, 
the recognition of molecular and genomic information in the relevant standards will be a key 
requirement for their acceptance as a reference method. 
 
Overall the strengths of molecular-based surveillance (and in extension genomic surveillance) 
include the ability to create high-resolution case definitions, ease of transport of samples in 
the absence of a cool chain, the rapid availability of results, international comparability and 
decreasing costs due to a high level of automatization. In addition, sequencing allows for the 
discovery of novel, yet unidentified hazards of any kind, including viruses, bacteria, or 
parasites. A further strength is the comprehensiveness of the information that can be 
obtained, including quantitative measures of pathogen occurrence and the ability to include 
evolutionary information into the data analysis which can super-charge the investigation of 
epidemiological links (Kao, 2015). 
 
The latter can at the same time pose a challenge as the generation and the interpretation of 
such complex results requires staff that are competent in specialist methods (e.g. 
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bioinformatics), and the surveillance team’s ability to successfully integrate different 
discipline such as epidemiology and molecular biology to allow for meaningful inferences 
that account for both pathogen and host population traits. This demand can delay the final 
interpretation of results despite the rapid availability of primary test outputs (Hasman et al., 
2014). Further results can easily be misinterpreted and  over-inferred from if underlying 
assumptions are not well understood and communicated  As in any diagnostic method, bias is 
regarded a shortcoming and needs to be minimised where possible, and acknowledged in the 
interpretation of results. Bias in the context of molecular or genomic data has many new faces 
not only relating to sample size or the representativeness of the sample, but also extending to 
– among others – the typability of a micro-organism, the reproducibility of the typing or 
sequencing technique as well as the match of the scale of the typing methods or analysis with 
the surveillance objective (Muellner 2011). Sensitivity can now relate to either analytical or 
diagnostic sensitivity which can be strongly impacted by the culture step. Some specific 
bacterial strains may be harder to culture than others which will introduce bias. So-called 
viable but non-culturable (VBNC) bacteria are found in aquatic animals as well as elsewhere 
(Li et al., 2014). Despite the low cost of analysing a sample, substantial investment in 
equipment is required. This could potentially be mitigated by creating analytical hubs within 
geographical regions, rather than each country developing its own specialist capacity.  
 
Further, at the operational level, regulatory weaknesses currently challenge next-generation 
surveillance. These include in particular gaps in quality assurance and standard setting. The 
latter may impact severely on trade, for example through ‘false-positive’ signals that point to 
associations, and therefore can create substantial hurdles to the implementation. However 
international and global efforts are currently being made to address this for example by the 
Global Microbal Identifier Working Group (Brisse et al., 2014). A problem is also the 
AC
CE
PT
ED
 M
AN
US
CR
IPT
12 
 
mutation from avirulent to virulent strains, as can be the case – for example – for infectious 
salmon anaemia. 
 
Due to their high resolution and the absence of the need of previous knowledge of the 
targeted agent, genome-based methods provide opportunities for early detection of agents, 
including pathogen discovery. Depending on the protocol, a culture step may not be required 
thus providing opportunities to reduce bias created by unculturable micro-organisms. The 
sequencing step itself is often outsourced to specialised companies that can provide rapid 
turn-around and high-quality readings as a service. The high cost of equipment is likely to 
encourage collaboration around centralised laboratories, thus not only increasing diagnostic 
efficiency but fostering inter-agency relationships. In addition, the inherent comparability of 
results and the increasing trend to share sequences on open platforms creates exciting 
opportunities for comparative analyses across regions and agents. Sequencing of the entire 
genome of an organism will also provide information that may not (yet) be in the focus of the 
analysis. Such additional information on virulence, resistance and other relevant genes adds 
value to the sample collected and increases the benefits from the sampling effort as several 
surveillance or research objectives can be investigated at once. However, this also requires a 
large research effort to help identify the relevant genetic markers. 
 
It is critical to note that molecular typing and genomic data, however advanced and detailed 
they may be, cannot compensate for sound epidemiological design of surveillance. Samples 
need to be representative of the population about which conclusions will be drawn and of a 
sufficient sample size. When samples are collected, additional epidemiological information 
needs to be captured (so-called meta-data) to allow for an appropriate interpretation at 
population level. Single isolates – even if analysed at nucleotide level – provide very limited 
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epidemiological value in the absence of information on the target population from which they 
were drawn. Therefore, in order to benefit from the plentiful opportunities provided by the 
use of molecular and genomic data in surveillance, all experts involved need to collaborate 
closely to assure that the results derived with are valid throughout the process and provide a 
robust basis for veterinary and public health decision-making. Integrative rather than parallel 
analysis should be promoted at all steps of the surveillance process. Good practice guidelines 
should be developed and promoted for adoption and an intensified dialogue between 
epidemiologists and microbiologists as well as bioinformatics experts is much needed. 
 
Finally, to ensure surveillance outputs provide “information for action”, communication of 
technical surveillance outputs to end-user is critical in the context of molecular surveillance, 
e.g. epidemiologist will need to understand the biological relevance of specific genetic 
markers while risk managers need comprehensive high-level summaries to inform their 
decision making. They are likely to struggle to extend their knowledge and training to all the 
different sub-discipline required for a successful molecular surveillance programme. With the 
increasing complexity of available data and analytical techniques the gaps in comprehension 
are widening. Without skilled guidance from experts, decision-makers will not be able to 
draw the right conclusions form the results presented.  
 
To increase the quality of publications based on molecular data, standards have been defined 
regarding the minimum information that should be provided for correct interpretation (e.g. 
STROME-ID, STROBE-AMR). While most medical journals are currently endorsing these 
statements, the list of veterinary journals is more limited (Strobe Vet Statement, 2016). It is 
hoped that more journals, including journals relevant to aquaculture, will apply these 
standards in the future.  A further challenge in the assurance of high-quality publications and 
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successful knowledge transfer is the competency of reviewers to recognize and assess the 
weaknesses of manuscripts using molecular and genomic data. Often, reviewers are either 
competent in molecular diagnostics or in surveillance design, but rarely in both. Inter-
disciplinary collaboration and sound editorial decision-making (e.g. supported through 
experienced Editorial Board Members) will be required to assure quality of published articles 
and the appropriate interpretation of surveillance results based on molecular and genomic 
data. 
 
Discussion  
While molecular and genomic typing tools can clearly super-charge surveillance systems and 
create exiting new opportunities to prevent and control infectious diseases, they need to be 
integrated in the wider context of surveillance and should not be considered stand-alone 
approaches. This is true for animal health surveillance in general, but also for surveillance 
applied in aquaculture. While diagnostic advantages offered by such methods could be 
attractive for a specific human patient, or a high-value animal patient, the use of genome-
based diagnosis is more complex in the context of population-based decision making 
(Ellington et al., 2017). There are additional, specific needs when operating in aquatic 
animals where the diversity as well as the interactions of aquatic systems presents a series of 
unique challenges and complexities due to the limited segregation between populations 
(Peeler & Taylor, 2011). 
  
Regardless of surveillance design, the sound foundation on epidemiological concepts is of 
paramount importance. Before engaging in molecular surveillance activities, we need to 
reflect on basic principles of diagnostic validity, misclassification risk and surveillance 
design, including risk-based surveillance. At the moment, many such gaps persist in the 
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context of molecular or genome-based diagnostics. More efforts are needed to work towards 
standardised operating procedures that assure the comparability between results. This is 
comparable to the development of standardised diagnostic procedures as used in the context 
of other trade-relevant biological hazards. Efforts have started for the validation for 
molecular tests (e.g. Saunders & Sharp, 2015; Cunha & Inàcio, 2015; Gioia et al., 2016). It is 
the responsibility of the standard setting organisations to consider novel diagnostic 
approaches and how they can (or cannot) contribute to decision making that is relevant to 
early detection of outbreaks, prevention of transmission and to trade.  
 
In animal disease surveillance, speed is not generally of a similar importance as if a human 
patient’s life were on the line. The additional costs of rapid diagnosis might therefore be hard 
to justify for routine surveillance where lower cost alternatives exist. One exception is 
surveillance in the wake of an outbreak, particularly if a listed (exotic) disease incursion is 
suspected, and when fast confirmation as well as rapid comparison to similar samples and 
high resolution typing will be essential to establish the sequence of transmission (Köser et al., 
2012). Particularly in aquaculture, where testing water may be attractive, a higher sensitivity 
will be an advantage for surveillance.  
 
Aquaculture is among the fastest growing sectors world-wide and a substantial proportion of 
products is traded internationally (Asche et al., 2016). While this offers opportunities to the 
sector, there are also risks. Animal health emergencies lead to trade disruption, and 
surveillance is one of the key tools for providing assurance to trading partner and therefore 
for building resilience towards unjustified rejection of products (Peeler et al., 2014). The lack 
of validated and accepted diagnostic tools provides a substantial hurdle for the establishment 
of the health status of a farm, region or country. The aquaculture sector may be differently 
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organised from other sectors due to different hazards causing disease and disease control 
measures that differ substantially from terrestrial animals. Therefore, alternative approaches 
may be required for surveillance in general, such as farmer involvement (Brugere et al., 
2017) or the sector may adopt advanced techniques and follow a different developmental 
pathway than terrestrial animal surveillance, which has long relied on comparative typing 
approaches. Finally, also the role of people in surveillance needs to be better understood and 
how they can best contribute and integrate with methods and tools to provide effective and 
efficient surveillance information to the sector’s advantage.  
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Figure 1: Strengths, weaknesses, opportunities and threats of surveillance based on molecular 
and genomic data 
 
 
AC
CE
PT
ED
 M
AN
US
CR
IPT
